Eitan Okun, Alzheimer’s disease researcher at Bar-Ilan University. Photo: courtesy

In April, we published a story on Israeli brain researcher Prof. Eitan Okun that sparked a great deal of interest from readers all over the world.

Okun is developing a vaccine against the degenerative brain disease, Alzheimer’s, which affects some 47 million people worldwide. His vaccine primes the body to attack amyloid beta protein accumulations in the brain, one of the signature signs of Alzheimer’s disease. Experiments on mice have been promising, and Okun is now preparing to design human trials on people at known risk of developing the disease.